|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 7.440 CAD | +19.04% |
|
+16.43% | +21.77% |
| 12-02 | Aurora Cannabis' MedReleaf Unit Signs Australia Distribution Deal With Leafio | MT |
| 12-02 | Aurora Cannabis Announcing Distribution Partnership with Leafio Australia | MT |
| Capitalization | 422M 306M 261M 244M 229M 27.72B 461M 2.84B 1.1B 13.07B 1.15B 1.12B 47.67B | P/E ratio 2026 * |
-10.5x | P/E ratio 2027 * | 67.6x |
|---|---|---|---|---|---|
| Enterprise value | 422M 306M 261M 244M 229M 27.72B 461M 2.84B 1.1B 13.07B 1.15B 1.12B 47.67B | EV / Sales 2026 * |
1.11x | EV / Sales 2027 * | 1.05x |
| Free-Float |
99.75% | Yield 2026 * |
-
| Yield 2027 * | - |
More valuation ratios
* Estimated data
More news
Last Transcript: Aurora Cannabis Inc.
More recommendations
More press releases
More news
| 1 day | +19.04% | ||
| 1 week | +16.43% | ||
| Current month | +15.71% | ||
| 1 month | +17.17% | ||
| 3 months | +10.06% | ||
| 6 months | -10.14% | ||
| Current year | +21.77% |
| 1 week | 6.15 |  | 7.56 |
| 1 month | 5.64 | | 7.56 |
| Current year | 4.95 | | 9.9 |
| 1 year | 4.95 | | 9.9 |
| 3 years | 3.84 | | 15.9 |
| 5 years | 3.84 | | 241 |
| 10 years | 3.84 | | 1,948.81 |
| Manager | Title | Age | Since |
|---|---|---|---|
Miguel Martin
CEO | Chief Executive Officer | 53 | 2020-09-07 |
Simona King
DFI | Director of Finance/CFO | 53 | 2024-02-20 |
Dave Aird
CTO | Chief Tech/Sci/R&D Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Michael Singer
CHM | Chairman | 60 | 2016-05-19 |
Norma Beauchamp
BRD | Director/Board Member | 64 | 2018-07-24 |
Miguel Martin
CHM | Chairman | 53 | 2024-09-19 |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +19.04% | +16.43% | +22.98% | -51.05% | 306M | |
| -1.10% | -3.05% | -22.21% | -35.16% | 6.3B | |
| +1.03% | +1.73% | -19.18% | +23.94% | 4.45B | |
| +0.50% | -0.69% | +40.51% | +53.44% | 4.37B | |
| -0.96% | -3.85% | -0.85% | -66.20% | 4.14B | |
| -0.50% | +1.61% | -7.95% | -12.23% | 3.63B | |
| -0.07% | -0.52% | +1.33% | +25.58% | 3.23B | |
| -0.12% | -3.36% | -5.04% | -38.84% | 2.45B | |
| +1.99% | -0.53% | +7.09% | -4.94% | 1.99B | |
| -0.70% | +7.51% | +7.83% | +59.03% | 1.8B | |
| Average | +1.91% | +1.94% | +2.45% | -4.65% | 3.27B | |
| Weighted average by Cap. | +0.06% | +0.07% | -1.63% | -4.02% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 380M 276M 235M 219M 206M 24.96B 415M 2.56B 993M 11.77B 1.03B 1.01B 42.93B | 400M 291M 247M 231M 218M 26.31B 437M 2.7B 1.05B 12.4B 1.09B 1.07B 45.25B |
| Net income | -35.1M -25.46M -21.69M -20.26M -19.07M -2.31B -38.35M -237M -91.74M -1.09B -95.54M -93.53M -3.97B | -200K -145K -124K -115K -109K -13.14M -218K -1.35M -523K -6.19M -544K -533K -22.6M |
| Net Debt | - | - |
More financial data
* Estimated data
Employees
1,073
Sector
Pharmaceuticals
Calendar
| Date | Price | Change | Volume |
|---|---|---|---|
| 25-12-12 | 7.440 $ | +19.04% | 2,332,274 |
| 25-12-11 | 6.250 $ | -0.16% | 221,195 |
| 25-12-10 | 6.260 $ | -1.26% | 276,917 |
| 25-12-09 | 6.340 $ | +2.09% | 300,542 |
| 25-12-08 | 6.210 $ | -2.82% | 245,393 |
Delayed Quote Toronto S.E., December 12, 2025 at 04:00 pm
More quotes
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
4
Last Close Price
7.440CAD
Average target price
7.800CAD
Spread / Average Target
+4.84%
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- ACB Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition